Practical model-based dose finding in early-phase clinical trials: Optimizing tissue plasminogen activator dose for treatment of ischemic stroke in children

Harry T. Whelan, John D. Cook, Catherine M. Amlie-Lefond, Collin A. Hovinga, Anthony K. Chan, Rebecca N. Ichord, Gabrielle A. Deveber, Peter F. Thall

Research output: Contribution to journal › Review article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Practical model-based dose finding in early-phase clinical trials: Optimizing tissue plasminogen activator dose for treatment of ischemic stroke in children'. Together they form a unique fingerprint.

Medicine & Life Sciences